n,SeriesName,gender,unit,SeriesCode,CountryName,CountryCode,year,value
1,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2001,0
2,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2001,0
9,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2001,20
10,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2001,23
11,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2001,54
12,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2001,50
25,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2001,0
26,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2001,0
29,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2001,0
30,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2001,0
31,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2001,1
32,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2001,1
35,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2001,0
36,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2001,0
39,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2001,0
40,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2001,0
49,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2001,12
50,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2001,12
51,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2001,0
52,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2001,0
61,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2001,0
62,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2001,0
65,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2001,4
66,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2001,3
69,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2001,47
70,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2001,46
85,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2001,0
86,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2001,0
87,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2001,0
88,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2001,0
89,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2001,77
90,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2001,67
99,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2001,45
100,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2001,57
109,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2001,0
110,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2001,0
111,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2001,0
112,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2001,0
113,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2001,49
114,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2001,61
115,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2001,0
116,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2001,0
117,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2001,0
118,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2001,0
121,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2001,0
122,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2001,0
125,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2001,0
126,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2001,0
129,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2001,1
130,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2001,1
131,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2001,8
132,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2001,5
141,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2001,50
142,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2001,39
145,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2001,0
146,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2001,0
147,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2001,1
148,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2001,2
149,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2001,0
150,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2001,0
155,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2001,10
156,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2001,9
159,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2001,0
160,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2001,0
163,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2001,0
164,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2001,0
165,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2001,0
166,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2001,0
169,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2001,0
170,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2001,0
171,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2001,49
172,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2001,58
173,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2001,39
174,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2001,39
179,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2001,0
180,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2001,0
181,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2001,44
182,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2001,50
185,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2001,0
186,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2001,0
189,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2001,0
190,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2001,0
191,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2001,0
192,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2001,0
195,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2001,0
196,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2001,0
197,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2001,0
198,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2001,0
199,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2001,0
200,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2001,0
205,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2001,3
206,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2001,3
209,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2001,0
210,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2001,0
211,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2001,0
212,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2001,0
213,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2001,38
214,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2001,29
215,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2001,0
216,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2001,0
223,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2001,0
224,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2001,0
225,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2001,1
226,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2001,0
227,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2001,0
228,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2001,0
233,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2001,10
234,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2001,9
235,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2001,0
236,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2001,1
237,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2001,0
238,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2001,0
239,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2001,13
240,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2001,15
241,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2001,0
242,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2001,0
245,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2001,0
246,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2001,0
251,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2001,0
252,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2001,0
253,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2001,0
254,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2001,0
255,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2002,0
256,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2002,0
263,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2002,24
264,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2002,26
265,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2002,52
266,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2002,47
279,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2002,0
280,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2002,0
283,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2002,0
284,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2002,0
285,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2002,2
286,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2002,3
289,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2002,0
290,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2002,0
293,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2002,0
294,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2002,0
303,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2002,17
304,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2002,17
305,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2002,1
306,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2002,2
315,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2002,0
316,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2002,0
319,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2002,7
320,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2002,6
323,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2002,48
324,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2002,47
339,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2002,0
340,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2002,0
341,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2002,0
342,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2002,0
343,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2002,76
344,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2002,69
353,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2002,45
354,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2002,56
363,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2002,0
364,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2002,0
365,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2002,1
366,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2002,1
367,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2002,55
368,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2002,72
369,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2002,0
370,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2002,0
371,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2002,0
372,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2002,0
375,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2002,0
376,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2002,0
379,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2002,0
380,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2002,0
383,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2002,1
384,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2002,2
385,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2002,13
386,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2002,8
395,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2002,51
396,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2002,43
399,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2002,0
400,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2002,0
401,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2002,8
402,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2002,3
403,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2002,0
404,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2002,0
409,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2002,13
410,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2002,11
413,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2002,0
414,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2002,0
417,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2002,0
418,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2002,0
419,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2002,0
420,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2002,0
423,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2002,0
424,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2002,0
425,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2002,50
426,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2002,64
427,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2002,42
428,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2002,45
433,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2002,0
434,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2002,0
435,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2002,53
436,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2002,61
439,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2002,2
440,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2002,3
443,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2002,0
444,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2002,0
445,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2002,2
446,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2002,2
449,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2002,0
450,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2002,0
451,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2002,0
452,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2002,0
453,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2002,0
454,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2002,0
459,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2002,4
460,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2002,4
463,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2002,1
464,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2002,0
465,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2002,0
466,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2002,0
467,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2002,44
468,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2002,33
469,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2002,0
470,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2002,0
477,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2002,0
478,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2002,0
479,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2002,2
480,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2002,1
481,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2002,0
482,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2002,0
487,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2002,12
488,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2002,9
489,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2002,1
490,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2002,1
491,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2002,0
492,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2002,0
493,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2002,15
494,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2002,17
495,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2002,0
496,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2002,0
499,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2002,0
500,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2002,0
505,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2002,0
506,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2002,0
507,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2002,0
508,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2002,0
509,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2003,0
510,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2003,0
517,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2003,26
518,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2003,29
519,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2003,51
520,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2003,46
533,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2003,0
534,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2003,0
537,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2003,1
538,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2003,0
539,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2003,6
540,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2003,7
543,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2003,2
544,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2003,1
547,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2003,0
548,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2003,0
557,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2003,20
558,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2003,21
559,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2003,3
560,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2003,4
569,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2003,1
570,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2003,0
573,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2003,9
574,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2003,8
577,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2003,49
578,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2003,49
593,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2003,0
594,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2003,0
595,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2003,0
596,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2003,0
597,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2003,76
598,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2003,72
607,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2003,44
608,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2003,56
617,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2003,1
618,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2003,1
619,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2003,6
620,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2003,5
621,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2003,62
622,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2003,75
623,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2003,0
624,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2003,0
625,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2003,0
626,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2003,0
629,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2003,0
630,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2003,0
633,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2003,0
634,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2003,0
637,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2003,2
638,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2003,2
639,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2003,17
640,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2003,10
649,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2003,49
650,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2003,41
653,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2003,0
654,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2003,0
655,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2003,13
656,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2003,5
657,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2003,1
658,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2003,1
663,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2003,16
664,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2003,14
667,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2003,0
668,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2003,10
671,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2003,4
672,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2003,5
673,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2003,0
674,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2003,0
677,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2003,0
678,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2003,0
679,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2003,51
680,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2003,68
681,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2003,45
682,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2003,50
687,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2003,1
688,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2003,1
689,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2003,61
690,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2003,71
693,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2003,4
694,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2003,4
697,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2003,0
698,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2003,0
699,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2003,3
700,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2003,4
703,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2003,0
704,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2003,0
705,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2003,0
706,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2003,0
707,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2003,0
708,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2003,0
713,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2003,4
714,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2003,4
717,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2003,1
718,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2003,1
719,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2003,0
720,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2003,0
721,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2003,49
722,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2003,37
723,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2003,0
724,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2003,0
731,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2003,0
732,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2003,0
733,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2003,4
734,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2003,3
735,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2003,0
736,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2003,0
741,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2003,13
742,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2003,9
743,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2003,2
744,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2003,2
745,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2003,0
746,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2003,0
747,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2003,17
748,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2003,19
749,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2003,0
750,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2003,0
753,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2003,0
754,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2003,0
759,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2003,2
760,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2003,2
761,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2003,0
762,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2003,0
763,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2004,0
764,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2004,0
771,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2004,30
772,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2004,31
773,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2004,51
774,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2004,46
787,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2004,0
788,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2004,0
791,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2004,1
792,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2004,1
793,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2004,12
794,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2004,14
797,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2004,4
798,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2004,4
801,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2004,0
802,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2004,0
811,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2004,22
812,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2004,22
813,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2004,4
814,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2004,5
823,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2004,1
824,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2004,1
827,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2004,11
828,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2004,10
831,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2004,51
832,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2004,50
847,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2004,1
848,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2004,1
849,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2004,9
850,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2004,4
851,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2004,75
852,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2004,74
861,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2004,44
862,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2004,55
871,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2004,1
872,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2004,1
873,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2004,8
874,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2004,7
875,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2004,67
876,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2004,83
877,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2004,0
878,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2004,0
879,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2004,0
880,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2004,0
883,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2004,0
884,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2004,0
887,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2004,2
888,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2004,2
891,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2004,2
892,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2004,3
893,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2004,20
894,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2004,12
903,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2004,48
904,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2004,43
907,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2004,1
908,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2004,1
909,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2004,17
910,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2004,6
911,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2004,4
912,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2004,3
917,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2004,17
918,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2004,16
921,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2004,0
922,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2004,6
925,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2004,6
926,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2004,7
927,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2004,0
928,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2004,0
931,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2004,0
932,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2004,0
933,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2004,51
934,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2004,72
935,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2004,48
936,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2004,55
941,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2004,2
942,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2004,3
943,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2004,69
944,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2004,80
947,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2004,6
948,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2004,4
951,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2004,0
952,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2004,0
953,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2004,2
954,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2004,2
957,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2004,3
958,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2004,3
959,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2004,0
960,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2004,0
961,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2004,0
962,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2004,0
967,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2004,5
968,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2004,5
971,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2004,2
972,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2004,1
973,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2004,0
974,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2004,0
975,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2004,54
976,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2004,41
977,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2004,0
978,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2004,1
985,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2004,0
986,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2004,0
987,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2004,9
988,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2004,7
989,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2004,0
990,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2004,0
995,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2004,13
996,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2004,8
997,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2004,5
998,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2004,7
999,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2004,0
1000,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2004,0
1001,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2004,19
1002,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2004,20
1003,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2004,0
1004,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2004,0
1007,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2004,0
1008,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2004,0
1013,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2004,4
1014,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2004,4
1015,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2004,1
1016,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2004,1
1017,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2005,0
1018,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2005,0
1025,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2005,34
1026,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2005,33
1027,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2005,53
1028,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2005,48
1041,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2005,0
1042,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2005,0
1045,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2005,2
1046,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2005,1
1047,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2005,18
1048,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2005,21
1051,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2005,8
1052,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2005,8
1055,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2005,12
1056,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2005,6
1065,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2005,30
1066,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2005,31
1067,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2005,5
1068,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2005,7
1077,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2005,4
1078,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2005,2
1081,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2005,13
1082,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2005,12
1085,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2005,51
1086,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2005,51
1101,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2005,3
1102,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2005,3
1103,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2005,9
1104,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2005,9
1105,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2005,74
1106,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2005,76
1115,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2005,43
1116,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2005,56
1125,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2005,3
1126,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2005,3
1127,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2005,12
1128,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2005,11
1129,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2005,72
1130,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2005,82
1131,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2005,1
1132,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2005,1
1133,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2005,0
1134,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2005,0
1137,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2005,6
1138,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2005,6
1141,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2005,4
1142,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2005,6
1145,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2005,2
1146,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2005,3
1147,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2005,22
1148,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2005,13
1157,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2005,50
1158,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2005,51
1161,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2005,4
1162,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2005,3
1163,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2005,21
1164,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2005,8
1165,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2005,4
1166,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2005,2
1171,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2005,19
1172,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2005,17
1175,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2005,1
1176,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2005,0
1179,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2005,7
1180,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2005,8
1181,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2005,1
1182,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2005,1
1185,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2005,1
1186,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2005,1
1187,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2005,51
1188,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2005,73
1189,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2005,47
1190,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2005,66
1195,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2005,3
1196,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2005,4
1197,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2005,76
1198,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2005,88
1201,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2005,3
1202,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2005,1
1205,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2005,5
1206,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2005,4
1207,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2005,6
1208,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2005,7
1211,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2005,10
1212,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2005,9
1213,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2005,3
1214,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2005,2
1215,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2005,0
1216,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2005,0
1221,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2005,9
1222,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2005,7
1225,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2005,4
1226,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2005,3
1227,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2005,0
1228,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2005,0
1229,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2005,59
1230,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2005,45
1231,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2005,1
1232,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2005,2
1239,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2005,1
1240,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2005,1
1241,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2005,17
1242,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2005,13
1243,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2005,0
1244,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2005,0
1249,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2005,14
1250,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2005,8
1251,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2005,9
1252,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2005,12
1253,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2005,1
1254,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2005,1
1255,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2005,21
1256,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2005,21
1257,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2005,0
1258,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2005,0
1261,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2005,1
1262,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2005,2
1267,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2005,6
1268,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2005,6
1269,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2005,2
1270,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2005,2
1271,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2006,0
1272,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2006,0
1279,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2006,35
1280,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2006,35
1281,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2006,56
1282,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2006,50
1295,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2006,0
1296,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2006,0
1299,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2006,2
1300,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2006,2
1301,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2006,25
1302,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2006,27
1305,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2006,14
1306,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2006,13
1309,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2006,19
1310,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2006,10
1319,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2006,28
1320,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2006,33
1321,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2006,7
1322,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2006,8
1331,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2006,6
1332,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2006,4
1335,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2006,15
1336,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2006,16
1339,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2006,53
1340,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2006,53
1355,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2006,9
1356,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2006,8
1357,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2006,13
1358,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2006,10
1359,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2006,74
1360,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2006,76
1369,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2006,43
1370,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2006,56
1379,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2006,8
1380,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2006,7
1381,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2006,17
1382,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2006,13
1383,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2006,73
1384,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2006,86
1385,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2006,2
1386,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2006,2
1387,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2006,2
1388,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2006,2
1391,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2006,8
1392,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2006,7
1395,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2006,9
1396,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2006,12
1399,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2006,3
1400,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2006,4
1401,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2006,23
1402,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2006,15
1411,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2006,53
1412,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2006,53
1415,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2006,8
1416,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2006,6
1417,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2006,25
1418,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2006,9
1419,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2006,10
1420,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2006,7
1425,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2006,22
1426,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2006,20
1429,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2006,1
1430,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2006,0
1433,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2006,8
1434,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2006,9
1435,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2006,3
1436,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2006,3
1439,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2006,2
1440,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2006,2
1441,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2006,52
1442,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2006,73
1443,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2006,47
1444,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2006,61
1449,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2006,7
1450,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2006,8
1451,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2006,84
1452,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2006,93
1455,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2006,2
1456,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2006,1
1459,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2006,9
1460,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2006,6
1461,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2006,9
1462,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2006,11
1465,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2006,18
1466,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2006,15
1467,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2006,5
1468,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2006,3
1469,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2006,0
1470,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2006,0
1475,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2006,14
1476,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2006,11
1479,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2006,7
1480,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2006,4
1481,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2006,0
1482,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2006,0
1483,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2006,63
1484,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2006,48
1485,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2006,2
1486,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2006,3
1493,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2006,4
1494,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2006,4
1495,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2006,21
1496,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2006,17
1497,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2006,2
1498,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2006,1
1503,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2006,14
1504,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2006,8
1505,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2006,9
1506,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2006,11
1507,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2006,2
1508,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2006,2
1509,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2006,24
1510,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2006,23
1511,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2006,7
1512,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2006,2
1515,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2006,5
1516,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2006,4
1521,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2006,10
1522,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2006,9
1523,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2006,5
1524,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2006,5
1525,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2007,0
1526,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2007,0
1533,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2007,40
1534,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2007,38
1535,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2007,55
1536,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2007,49
1549,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2007,0
1550,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2007,0
1553,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2007,3
1554,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2007,2
1555,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2007,29
1556,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2007,32
1559,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2007,17
1560,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2007,16
1563,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2007,28
1564,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2007,15
1573,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2007,30
1574,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2007,35
1575,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2007,13
1576,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2007,14
1585,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2007,8
1586,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2007,5
1589,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2007,18
1590,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2007,18
1593,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2007,54
1594,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2007,54
1609,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2007,17
1610,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2007,16
1611,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2007,13
1612,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2007,13
1613,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2007,75
1614,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2007,76
1623,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2007,43
1624,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2007,55
1633,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2007,11
1634,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2007,11
1635,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2007,21
1636,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2007,17
1637,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2007,74
1638,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2007,88
1639,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2007,4
1640,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2007,5
1641,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2007,2
1642,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2007,3
1645,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2007,12
1646,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2007,11
1649,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2007,13
1650,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2007,17
1653,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2007,6
1654,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2007,7
1655,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2007,26
1656,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2007,17
1665,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2007,52
1666,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2007,49
1669,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2007,13
1670,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2007,10
1671,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2007,27
1672,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2007,11
1673,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2007,15
1674,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2007,10
1679,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2007,24
1680,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2007,22
1683,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2007,1
1684,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2007,0
1687,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2007,9
1688,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2007,11
1689,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2007,5
1690,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2007,4
1693,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2007,6
1694,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2007,4
1695,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2007,53
1696,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2007,75
1697,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2007,48
1698,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2007,63
1703,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2007,8
1704,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2007,9
1705,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2007,91
1706,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2007,97
1709,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2007,5
1710,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2007,2
1713,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2007,12
1714,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2007,9
1715,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2007,13
1716,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2007,25
1719,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2007,24
1720,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2007,20
1721,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2007,8
1722,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2007,4
1723,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2007,26
1724,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2007,10
1729,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2007,20
1730,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2007,16
1733,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2007,11
1734,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2007,7
1735,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2007,0
1736,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2007,0
1737,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2007,68
1738,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2007,52
1739,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2007,2
1740,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2007,4
1747,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2007,10
1748,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2007,11
1749,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2007,26
1750,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2007,21
1751,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2007,2
1752,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2007,1
1757,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2007,14
1758,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2007,7
1759,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2007,11
1760,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2007,14
1761,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2007,3
1762,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2007,3
1763,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2007,26
1764,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2007,23
1765,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2007,12
1766,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2007,5
1769,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2007,9
1770,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2007,8
1775,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2007,18
1776,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2007,17
1777,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2007,8
1778,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2007,8
1779,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2008,0
1780,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2008,0
1787,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2008,42
1788,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2008,41
1789,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2008,54
1790,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2008,48
1803,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2008,25
1804,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2008,16
1807,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2008,4
1808,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2008,3
1809,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2008,36
1810,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2008,39
1813,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2008,23
1814,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2008,21
1817,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2008,34
1818,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2008,19
1827,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2008,31
1828,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2008,36
1829,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2008,11
1830,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2008,12
1839,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2008,13
1840,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2008,8
1843,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2008,22
1844,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2008,22
1847,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2008,58
1848,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2008,58
1863,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2008,24
1864,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2008,23
1865,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2008,18
1866,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2008,14
1867,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2008,75
1868,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2008,76
1877,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2008,43
1878,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2008,54
1887,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2008,16
1888,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2008,16
1889,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2008,24
1890,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2008,19
1891,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2008,75
1892,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2008,85
1893,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2008,7
1894,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2008,8
1895,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2008,3
1896,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2008,3
1899,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2008,15
1900,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2008,13
1903,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2008,17
1904,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2008,23
1907,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2008,7
1908,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2008,8
1909,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2008,29
1910,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2008,18
1919,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2008,55
1920,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2008,50
1923,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2008,20
1924,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2008,16
1925,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2008,30
1926,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2008,12
1927,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2008,21
1928,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2008,14
1933,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2008,26
1934,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2008,24
1937,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2008,2
1938,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2008,0
1941,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2008,12
1942,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2008,14
1943,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2008,8
1944,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2008,5
1947,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2008,11
1948,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2008,7
1949,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2008,57
1950,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2008,76
1951,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2008,49
1952,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2008,64
1957,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2008,15
1958,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2008,16
1959,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2008,93
1960,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2008,97
1963,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2008,5
1964,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2008,2
1967,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2008,18
1968,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2008,13
1969,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2008,15
1970,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2008,28
1973,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2008,32
1974,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2008,28
1975,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2008,12
1976,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2008,7
1977,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2008,31
1978,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2008,12
1983,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2008,28
1984,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2008,22
1987,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2008,15
1988,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2008,11
1989,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2008,0
1990,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2008,0
1991,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2008,72
1992,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2008,56
1993,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2008,3
1994,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2008,5
2001,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2008,12
2002,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2008,12
2003,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2008,30
2004,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2008,25
2005,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2008,11
2006,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2008,4
2011,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2008,15
2012,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2008,7
2013,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2008,15
2014,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2008,19
2015,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2008,4
2016,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2008,4
2017,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2008,27
2018,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2008,23
2019,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2008,17
2020,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2008,7
2023,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2008,14
2024,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2008,14
2029,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2008,25
2030,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2008,23
2031,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2008,12
2032,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2008,12
2033,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2009,1
2034,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2009,1
2041,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2009,46
2042,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2009,43
2043,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2009,54
2044,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2009,49
2057,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2009,33
2058,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2009,21
2061,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2009,6
2062,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2009,5
2063,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2009,47
2064,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2009,41
2067,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2009,29
2068,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2009,26
2071,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2009,36
2072,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2009,20
2081,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2009,34
2082,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2009,39
2083,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2009,11
2084,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2009,12
2093,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2009,18
2094,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2009,12
2097,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2009,26
2098,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2009,26
2101,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2009,61
2102,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2009,62
2117,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2009,32
2118,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2009,31
2119,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2009,20
2120,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2009,16
2121,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2009,76
2122,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2009,76
2131,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2009,43
2132,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2009,52
2141,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2009,21
2142,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2009,20
2143,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2009,29
2144,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2009,22
2145,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2009,75
2146,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2009,86
2147,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2009,11
2148,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2009,11
2149,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2009,4
2150,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2009,5
2153,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2009,20
2154,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2009,19
2157,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2009,24
2158,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2009,31
2161,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2009,8
2162,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2009,10
2163,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2009,31
2164,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2009,22
2173,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2009,54
2174,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2009,51
2177,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2009,26
2178,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2009,20
2179,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2009,32
2180,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2009,14
2181,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2009,26
2182,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2009,17
2187,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2009,27
2188,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2009,26
2191,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2009,3
2192,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2009,2
2195,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2009,14
2196,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2009,15
2197,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2009,10
2198,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2009,7
2201,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2009,14
2202,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2009,10
2203,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2009,60
2204,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2009,76
2205,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2009,51
2206,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2009,65
2211,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2009,19
2212,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2009,21
2213,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2009,94
2214,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2009,96
2217,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2009,5
2218,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2009,2
2221,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2009,23
2222,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2009,17
2223,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2009,22
2224,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2009,39
2227,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2009,39
2228,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2009,34
2229,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2009,17
2230,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2009,10
2231,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2009,35
2232,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2009,15
2237,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2009,37
2238,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2009,29
2241,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2009,21
2242,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2009,15
2243,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2009,2
2244,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2009,2
2245,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2009,77
2246,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2009,59
2247,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2009,4
2248,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2009,7
2255,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2009,15
2256,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2009,16
2257,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2009,34
2258,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2009,29
2259,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2009,11
2260,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2009,4
2265,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2009,16
2266,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2009,10
2267,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2009,17
2268,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2009,21
2269,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2009,6
2270,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2009,6
2271,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2009,28
2272,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2009,23
2273,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2009,21
2274,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2009,8
2277,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2009,18
2278,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2009,18
2283,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2009,30
2284,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2009,29
2285,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2009,18
2286,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2009,18
2287,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2010,1
2288,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2010,1
2295,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2010,49
2296,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2010,46
2297,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2010,59
2298,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2010,53
2311,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2010,40
2312,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2010,25
2315,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2010,7
2316,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2010,6
2317,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2010,53
2318,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2010,46
2321,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2010,35
2322,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2010,32
2325,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2010,40
2326,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2010,26
2335,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2010,35
2336,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2010,41
2337,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2010,13
2338,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2010,13
2347,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2010,20
2348,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2010,13
2351,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2010,31
2352,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2010,30
2355,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2010,64
2356,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2010,65
2371,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2010,39
2372,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2010,38
2373,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2010,23
2374,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2010,16
2375,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2010,76
2376,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2010,76
2385,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2010,43
2386,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2010,49
2395,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2010,23
2396,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2010,21
2397,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2010,31
2398,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2010,26
2399,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2010,75
2400,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2010,85
2401,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2010,16
2402,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2010,15
2403,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2010,5
2404,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2010,5
2407,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2010,21
2408,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2010,22
2411,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2010,30
2412,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2010,38
2415,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2010,10
2416,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2010,11
2417,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2010,34
2418,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2010,24
2427,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2010,56
2428,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2010,53
2431,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2010,32
2432,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2010,25
2433,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2010,34
2434,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2010,15
2435,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2010,30
2436,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2010,20
2441,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2010,28
2442,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2010,27
2445,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2010,7
2446,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2010,7
2449,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2010,16
2450,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2010,18
2451,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2010,14
2452,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2010,10
2455,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2010,19
2456,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2010,14
2457,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2010,63
2458,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2010,78
2459,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2010,55
2460,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2010,67
2465,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2010,24
2466,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2010,19
2467,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2010,95
2468,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2010,94
2471,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2010,5
2472,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2010,2
2475,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2010,29
2476,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2010,23
2477,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2010,31
2478,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2010,44
2481,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2010,45
2482,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2010,40
2483,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2010,23
2484,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2010,14
2485,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2010,40
2486,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2010,17
2491,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2010,24
2492,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2010,35
2495,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2010,27
2496,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2010,21
2497,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2010,2
2498,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2010,2
2499,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2010,78
2500,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2010,64
2501,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2010,5
2502,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2010,9
2509,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2010,21
2510,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2010,15
2511,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2010,39
2512,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2010,34
2513,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2010,16
2514,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2010,6
2519,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2010,18
2520,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2010,9
2521,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2010,21
2522,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2010,26
2523,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2010,9
2524,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2010,9
2525,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2010,38
2526,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2010,29
2527,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2010,26
2528,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2010,10
2531,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2010,24
2532,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2010,23
2537,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2010,35
2538,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2010,34
2539,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2010,33
2540,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2010,26
2541,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2011,2
2542,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2011,3
2549,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2011,52
2550,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2011,49
2551,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2011,61
2552,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2011,55
2565,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2011,49
2566,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2011,31
2569,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2011,7
2570,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2011,6
2571,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2011,57
2572,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2011,51
2575,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2011,48
2576,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2011,27
2579,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2011,49
2580,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2011,26
2589,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2011,36
2590,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2011,41
2591,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2011,20
2592,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2011,19
2601,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2011,24
2602,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2011,17
2605,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2011,37
2606,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2011,35
2609,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2011,67
2610,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2011,69
2625,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2011,46
2626,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2011,45
2627,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2011,23
2628,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2011,17
2629,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2011,76
2630,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2011,77
2639,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2011,44
2640,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2011,48
2649,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2011,27
2650,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2011,25
2651,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2011,36
2652,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2011,29
2653,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2011,75
2654,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2011,83
2655,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2011,21
2656,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2011,18
2657,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2011,5
2658,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2011,6
2661,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2011,24
2662,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2011,25
2665,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2011,43
2666,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2011,37
2669,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2011,11
2670,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2011,13
2671,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2011,37
2672,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2011,27
2681,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2011,59
2682,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2011,55
2685,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2011,41
2686,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2011,31
2687,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2011,35
2688,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2011,17
2689,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2011,40
2690,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2011,19
2695,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2011,30
2696,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2011,28
2699,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2011,9
2700,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2011,12
2703,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2011,20
2704,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2011,22
2705,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2011,18
2706,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2011,14
2709,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2011,25
2710,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2011,19
2711,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2011,66
2712,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2011,78
2713,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2011,58
2714,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2011,73
2719,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2011,27
2720,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2011,22
2721,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2011,95
2722,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2011,92
2725,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2011,5
2726,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2011,2
2729,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2011,29
2730,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2011,23
2731,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2011,33
2732,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2011,46
2735,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2011,49
2736,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2011,45
2737,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2011,29
2738,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2011,18
2739,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2011,43
2740,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2011,19
2745,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2011,28
2746,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2011,41
2749,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2011,35
2750,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2011,28
2751,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2011,3
2752,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2011,2
2753,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2011,79
2754,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2011,65
2755,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2011,6
2756,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2011,11
2763,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2011,22
2764,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2011,17
2765,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2011,43
2766,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2011,39
2767,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2011,13
2768,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2011,5
2773,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2011,19
2774,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2011,9
2775,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2011,24
2776,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2011,29
2777,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2011,11
2778,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2011,11
2779,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2011,41
2780,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2011,29
2781,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2011,31
2782,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2011,12
2785,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2011,30
2786,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2011,27
2791,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2011,41
2792,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2011,40
2793,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2011,45
2794,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2011,32
2795,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2012,3
2796,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2012,3
2803,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2012,54
2804,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2012,51
2805,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2012,63
2806,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2012,57
2819,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2012,52
2820,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2012,34
2823,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2012,12
2824,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2012,12
2825,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2012,66
2826,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2012,54
2829,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2012,51
2830,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2012,29
2833,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2012,56
2834,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2012,32
2843,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2012,42
2844,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2012,44
2845,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2012,28
2846,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2012,25
2855,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2012,28
2856,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2012,19
2859,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2012,42
2860,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2012,38
2863,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2012,70
2864,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2012,72
2879,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2012,53
2880,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2012,46
2881,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2012,32
2882,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2012,25
2883,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2012,77
2884,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2012,77
2893,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2012,45
2894,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2012,49
2903,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2012,36
2904,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2012,28
2905,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2012,40
2906,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2012,32
2907,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2012,75
2908,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2012,83
2909,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2012,26
2910,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2012,22
2911,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2012,6
2912,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2012,7
2915,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2012,27
2916,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2012,28
2919,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2012,47
2920,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2012,40
2923,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2012,12
2924,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2012,14
2925,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2012,38
2926,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2012,28
2935,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2012,62
2936,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2012,60
2939,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2012,52
2940,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2012,37
2941,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2012,35
2942,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2012,17
2943,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2012,38
2944,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2012,18
2949,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2012,31
2950,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2012,40
2953,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2012,12
2954,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2012,11
2957,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2012,27
2958,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2012,26
2959,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2012,24
2960,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2012,18
2963,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2012,29
2964,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2012,24
2965,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2012,69
2966,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2012,78
2967,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2012,59
2968,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2012,70
2973,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2012,39
2974,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2012,22
2975,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2012,95
2976,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2012,91
2979,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2012,7
2980,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2012,3
2983,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2012,30
2984,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2012,29
2985,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2012,41
2986,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2012,56
2989,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2012,57
2990,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2012,51
2991,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2012,35
2992,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2012,24
2993,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2012,40
2994,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2012,19
2999,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2012,34
3000,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2012,46
3003,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2012,43
3004,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2012,35
3005,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2012,4
3006,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2012,3
3007,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2012,80
3008,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2012,68
3009,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2012,8
3010,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2012,13
3017,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2012,35
3018,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2012,25
3019,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2012,48
3020,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2012,42
3021,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2012,15
3022,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2012,10
3027,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2012,14
3028,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2012,11
3029,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2012,36
3030,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2012,32
3031,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2012,17
3032,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2012,18
3033,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2012,38
3034,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2012,28
3035,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2012,11
3036,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2012,4
3039,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2012,38
3040,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2012,30
3045,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2012,43
3046,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2012,47
3047,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2012,51
3048,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2012,38
3049,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2013,3
3050,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2013,4
3057,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2013,56
3058,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2013,53
3059,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2013,73
3060,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2013,61
3073,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2013,45
3074,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2013,30
3077,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2013,15
3078,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2013,15
3079,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2013,69
3080,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2013,61
3083,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2013,56
3084,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2013,32
3087,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2013,62
3088,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2013,37
3097,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2013,46
3098,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2013,53
3099,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2013,34
3100,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2013,29
3109,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2013,31
3110,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2013,22
3113,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2013,46
3114,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2013,42
3117,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2013,71
3118,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2013,69
3133,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2013,55
3134,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2013,52
3135,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2013,30
3136,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2013,24
3137,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2013,77
3138,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2013,77
3147,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2013,48
3148,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2013,50
3157,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2013,46
3158,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2013,34
3159,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2013,45
3160,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2013,35
3161,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2013,74
3162,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2013,81
3163,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2013,33
3164,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2013,28
3165,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2013,7
3166,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2013,8
3169,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2013,35
3170,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2013,29
3173,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2013,51
3174,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2013,42
3177,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2013,14
3178,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2013,15
3179,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2013,40
3180,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2013,28
3189,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2013,62
3190,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2013,59
3193,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2013,59
3194,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2013,42
3195,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2013,40
3196,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2013,20
3197,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2013,39
3198,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2013,17
3203,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2013,32
3204,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2013,39
3207,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2013,21
3208,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2013,16
3211,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2013,32
3212,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2013,31
3213,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2013,30
3214,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2013,22
3217,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2013,33
3218,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2013,28
3219,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2013,73
3220,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2013,79
3221,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2013,61
3222,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2013,70
3227,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2013,45
3228,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2013,28
3229,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2013,95
3230,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2013,89
3233,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2013,6
3234,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2013,3
3237,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2013,35
3238,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2013,32
3239,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2013,41
3240,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2013,55
3243,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2013,64
3244,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2013,56
3245,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2013,45
3246,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2013,24
3247,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2013,44
3248,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2013,25
3253,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2013,54
3254,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2013,51
3257,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2013,49
3258,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2013,41
3259,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2013,6
3260,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2013,5
3261,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2013,81
3262,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2013,70
3263,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2013,12
3264,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2013,17
3271,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2013,41
3272,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2013,28
3273,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2013,53
3274,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2013,48
3275,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2013,31
3276,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2013,13
3281,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2013,16
3282,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2013,12
3283,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2013,51
3284,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2013,37
3285,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2013,23
3286,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2013,24
3287,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2013,61
3288,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2013,40
3289,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2013,25
3290,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2013,10
3293,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2013,41
3294,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2013,35
3299,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2013,49
3300,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2013,52
3301,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2013,54
3302,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2013,52
3303,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2014,5
3304,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2014,4
3311,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2014,59
3312,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2014,56
3313,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2014,77
3314,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2014,64
3327,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2014,51
3328,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2014,35
3331,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2014,18
3332,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2014,19
3333,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2014,72
3334,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2014,61
3337,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2014,63
3338,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2014,35
3341,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2014,71
3342,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2014,47
3351,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2014,50
3352,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2014,48
3353,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2014,41
3354,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2014,34
3363,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2014,37
3364,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2014,25
3367,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2014,53
3368,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2014,49
3371,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2014,75
3372,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2014,79
3387,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2014,62
3388,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2014,59
3389,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2014,32
3390,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2014,25
3391,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2014,78
3392,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2014,77
3401,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2014,52
3402,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2014,52
3411,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2014,50
3412,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2014,39
3413,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2014,47
3414,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2014,38
3415,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2014,74
3416,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2014,82
3417,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2014,37
3418,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2014,31
3419,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2014,9
3420,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2014,11
3423,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2014,37
3424,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2014,31
3427,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2014,59
3428,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2014,47
3431,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2014,15
3432,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2014,16
3433,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2014,43
3434,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2014,30
3443,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2014,65
3444,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2014,63
3447,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2014,66
3448,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2014,48
3449,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2014,48
3450,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2014,25
3451,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2014,41
3452,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2014,19
3457,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2014,34
3458,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2014,39
3461,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2014,27
3462,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2014,21
3465,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2014,36
3466,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2014,35
3467,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2014,38
3468,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2014,28
3471,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2014,38
3472,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2014,35
3473,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2014,76
3474,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2014,79
3475,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2014,64
3476,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2014,72
3481,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2014,49
3482,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2014,32
3483,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2014,95
3484,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2014,88
3487,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2014,7
3488,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2014,4
3491,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2014,39
3492,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2014,36
3493,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2014,46
3494,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2014,61
3497,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2014,71
3498,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2014,61
3499,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2014,55
3500,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2014,30
3501,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2014,52
3502,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2014,29
3507,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2014,55
3508,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2014,58
3511,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2014,54
3512,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2014,45
3513,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2014,10
3514,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2014,6
3515,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2014,82
3516,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2014,71
3517,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2014,15
3518,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2014,19
3525,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2014,51
3526,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2014,32
3527,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2014,57
3528,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2014,52
3529,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2014,32
3530,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2014,15
3535,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2014,17
3536,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2014,15
3537,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2014,61
3538,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2014,47
3539,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2014,27
3540,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2014,29
3541,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2014,63
3542,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2014,41
3543,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2014,36
3544,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2014,15
3547,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2014,44
3548,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2014,38
3553,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2014,58
3554,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2014,55
3555,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2014,64
3556,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2014,53
3557,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2015,6
3558,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2015,5
3565,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2015,61
3566,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2015,58
3567,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2015,79
3568,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2015,68
3581,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2015,58
3582,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2015,41
3585,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2015,25
3586,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2015,25
3587,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2015,78
3588,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2015,66
3591,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2015,70
3592,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2015,41
3595,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2015,77
3596,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2015,51
3605,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2015,51
3606,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2015,53
3607,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2015,49
3608,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2015,39
3617,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2015,42
3618,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2015,29
3621,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2015,60
3622,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2015,56
3625,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2015,77
3626,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2015,82
3641,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2015,63
3642,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2015,65
3643,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2015,29
3644,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2015,24
3645,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2015,79
3646,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2015,78
3655,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2015,56
3656,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2015,54
3665,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2015,55
3666,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2015,42
3667,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2015,51
3668,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2015,41
3669,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2015,73
3670,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2015,81
3671,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2015,42
3672,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2015,34
3673,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2015,11
3674,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2015,13
3677,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2015,39
3678,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2015,33
3681,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2015,69
3682,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2015,56
3685,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2015,15
3686,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2015,17
3687,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2015,44
3688,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2015,31
3697,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2015,66
3698,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2015,67
3701,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2015,71
3702,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2015,52
3703,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2015,50
3704,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2015,31
3705,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2015,45
3706,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2015,22
3711,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2015,40
3712,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2015,44
3715,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2015,28
3716,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2015,28
3719,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2015,49
3720,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2015,38
3721,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2015,47
3722,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2015,35
3725,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2015,43
3726,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2015,40
3727,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2015,78
3728,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2015,80
3729,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2015,68
3730,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2015,73
3735,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2015,53
3736,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2015,36
3737,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2015,96
3738,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2015,87
3741,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2015,7
3742,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2015,5
3745,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2015,43
3746,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2015,39
3747,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2015,44
3748,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2015,80
3751,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2015,77
3752,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2015,68
3753,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2015,68
3754,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2015,44
3755,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2015,57
3756,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2015,35
3761,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2015,65
3762,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2015,62
3765,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2015,59
3766,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2015,50
3767,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2015,17
3768,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2015,9
3769,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2015,83
3770,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2015,74
3771,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2015,19
3772,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2015,24
3779,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2015,56
3780,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2015,37
3781,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2015,63
3782,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2015,58
3783,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2015,29
3784,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2015,18
3789,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2015,19
3790,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2015,15
3791,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2015,65
3792,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2015,50
3793,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2015,28
3794,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2015,28
3795,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2015,60
3796,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2015,46
3797,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2015,44
3798,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2015,19
3801,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2015,52
3802,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2015,45
3807,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2015,65
3808,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2015,62
3809,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2015,69
3810,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2015,59
3811,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2016,11
3812,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2016,6
3819,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2016,63
3820,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2016,60
3821,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2016,80
3822,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2016,71
3835,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2016,65
3836,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2016,46
3839,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2016,29
3840,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2016,30
3841,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2016,83
3842,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2016,70
3845,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2016,77
3846,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2016,44
3849,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2016,90
3850,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2016,58
3859,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2016,57
3860,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2016,50
3861,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2016,56
3862,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2016,45
3871,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2016,52
3872,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2016,34
3875,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2016,65
3876,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2016,60
3879,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2016,80
3880,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2016,85
3895,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2016,71
3896,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2016,69
3897,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2016,30
3898,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2016,21
3899,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2016,78
3900,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2016,80
3909,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2016,61
3910,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2016,57
3919,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2016,65
3920,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2016,51
3921,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2016,53
3922,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2016,44
3923,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2016,73
3924,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2016,82
3925,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2016,48
3926,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2016,38
3927,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2016,14
3928,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2016,15
3931,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2016,42
3932,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2016,36
3935,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2016,78
3936,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2016,62
3939,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2016,31
3940,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2016,29
3941,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2016,48
3942,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2016,38
3951,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2016,68
3952,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2016,68
3955,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2016,79
3956,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2016,59
3957,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2016,63
3958,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2016,43
3959,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2016,48
3960,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2016,25
3965,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2016,44
3966,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2016,45
3969,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2016,30
3970,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2016,25
3973,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2016,57
3974,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2016,45
3975,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2016,56
3976,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2016,42
3979,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2016,46
3980,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2016,44
3981,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2016,80
3982,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2016,80
3983,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2016,73
3984,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2016,74
3989,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2016,59
3990,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2016,41
3991,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2016,95
3992,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2016,86
3995,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2016,8
3996,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2016,6
3999,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2016,50
4000,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2016,44
4001,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2016,54
4002,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2016,72
4005,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2016,84
4006,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2016,77
4007,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2016,77
4008,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2016,55
4009,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2016,70
4010,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2016,37
4015,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2016,67
4016,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2016,65
4019,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2016,65
4020,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2016,56
4021,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2016,16
4022,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2016,10
4023,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2016,84
4024,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2016,81
4025,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2016,27
4026,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2016,32
4033,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2016,62
4034,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2016,42
4035,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2016,69
4036,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2016,65
4037,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2016,37
4038,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2016,19
4043,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2016,22
4044,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2016,17
4045,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2016,71
4046,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2016,57
4047,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2016,39
4048,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2016,39
4049,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2016,61
4050,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2016,45
4051,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2016,54
4052,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2016,24
4055,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2016,57
4056,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2016,49
4061,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2016,67
4062,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2016,64
4063,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2016,75
4064,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2016,63
4065,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2017,11
4066,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2017,10
4073,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2017,65
4074,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2017,62
4075,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2017,81
4076,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2017,73
4089,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2017,65
4090,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2017,47
4093,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2017,34
4094,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2017,34
4095,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2017,85
4096,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2017,74
4099,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2017,89
4100,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2017,48
4103,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2017,98
4104,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2017,59
4113,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2017,63
4114,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2017,54
4115,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2017,61
4116,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2017,49
4125,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2017,64
4126,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2017,40
4129,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2017,69
4130,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2017,64
4133,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2017,83
4134,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2017,86
4149,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2017,73
4150,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2017,72
4151,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2017,34
4152,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2017,22
4153,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2017,82
4154,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2017,80
4163,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2017,63
4164,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2017,60
4173,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2017,72
4174,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2017,57
4175,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2017,56
4176,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2017,47
4177,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2017,83
4178,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2017,76
4179,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2017,53
4180,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2017,42
4181,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2017,17
4182,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2017,17
4185,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2017,46
4186,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2017,38
4189,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2017,84
4190,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2017,69
4193,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2017,37
4194,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2017,33
4195,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2017,54
4196,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2017,39
4205,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2017,70
4206,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2017,69
4209,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2017,85
4210,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2017,67
4211,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2017,66
4212,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2017,46
4213,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2017,53
4214,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2017,27
4219,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2017,45
4220,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2017,46
4223,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2017,33
4224,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2017,28
4227,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2017,57
4228,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2017,52
4229,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2017,63
4230,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2017,49
4233,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2017,54
4234,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2017,50
4235,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2017,83
4236,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2017,81
4237,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2017,77
4238,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2017,73
4243,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2017,61
4244,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2017,43
4245,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2017,94
4246,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2017,86
4249,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2017,9
4250,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2017,7
4253,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2017,60
4254,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2017,48
4255,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2017,60
4256,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2017,68
4259,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2017,87
4260,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2017,80
4261,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2017,94
4262,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2017,68
4263,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2017,76
4264,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2017,43
4269,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2017,68
4270,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2017,70
4273,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2017,71
4274,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2017,61
4275,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2017,18
4276,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2017,15
4277,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2017,86
4278,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2017,83
4279,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2017,34
4280,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2017,37
4287,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2017,68
4288,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2017,48
4289,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2017,73
4290,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2017,70
4291,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2017,34
4292,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2017,23
4297,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2017,21
4298,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2017,18
4299,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2017,79
4300,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2017,66
4301,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2017,44
4302,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2017,44
4303,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2017,63
4304,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2017,50
4305,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2017,65
4306,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2017,31
4309,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2017,62
4310,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2017,56
4315,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2017,71
4316,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2017,65
4317,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2017,84
4318,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2017,74
4319,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2018,10
4320,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2018,11
4327,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2018,66
4328,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2018,63
4329,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2018,82
4330,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2018,76
4343,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2018,80
4344,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2018,45
4347,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2018,45
4348,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2018,38
4349,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2018,92
4350,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2018,77
4353,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2018,83
4354,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2018,46
4357,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2018,98
4358,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2018,73
4367,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2018,66
4368,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2018,58
4369,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2018,59
4370,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2018,49
4379,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2018,71
4380,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2018,49
4383,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2018,73
4384,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2018,69
4387,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2018,86
4388,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2018,85
4403,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2018,75
4404,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2018,75
4405,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2018,38
4406,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2018,26
4407,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2018,81
4408,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2018,85
4417,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2018,67
4418,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2018,64
4427,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2018,67
4428,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2018,57
4429,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2018,58
4430,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2018,49
4431,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2018,86
4432,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2018,89
4433,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2018,61
4434,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2018,49
4435,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2018,20
4436,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2018,19
4439,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2018,49
4440,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2018,40
4443,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2018,81
4444,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2018,68
4447,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2018,41
4448,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2018,36
4449,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2018,58
4450,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2018,44
4459,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2018,70
4460,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2018,71
4463,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2018,91
4464,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2018,73
4465,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2018,65
4466,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2018,48
4467,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2018,58
4468,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2018,31
4473,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2018,51
4474,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2018,48
4477,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2018,35
4478,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2018,29
4481,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2018,64
4482,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2018,61
4483,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2018,70
4484,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2018,57
4487,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2018,59
4488,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2018,56
4489,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2018,84
4490,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2018,82
4491,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2018,80
4492,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2018,75
4497,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2018,62
4498,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2018,46
4499,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2018,94
4500,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2018,87
4503,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2018,11
4504,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2018,9
4507,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2018,64
4508,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2018,50
4509,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2018,68
4510,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2018,70
4513,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2018,89
4514,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2018,83
4515,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2018,98
4516,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2018,75
4517,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2018,87
4518,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2018,50
4523,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2018,70
4524,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2018,72
4527,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2018,74
4528,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2018,65
4529,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2018,23
4530,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2018,18
4531,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2018,86
4532,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2018,84
4533,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2018,43
4534,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2018,43
4541,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2018,75
4542,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2018,55
4543,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2018,77
4544,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2018,74
4545,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2018,38
4546,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2018,31
4551,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2018,24
4552,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2018,20
4553,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2018,83
4554,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2018,71
4555,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2018,51
4556,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2018,51
4557,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2018,67
4558,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2018,58
4559,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2018,75
4560,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2018,37
4563,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2018,67
4564,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2018,59
4569,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2018,79
4570,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2018,72
4571,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2018,88
4572,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2018,79
4573,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2019,11
4574,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2019,11
4581,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2019,69
4582,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2019,66
4583,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2019,83
4584,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2019,79
4597,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2019,83
4598,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2019,60
4601,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2019,51
4602,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2019,44
4603,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2019,92
4604,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2019,80
4607,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2019,94
4608,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2019,55
4611,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2019,98
4612,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2019,76
4621,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2019,68
4622,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2019,61
4623,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2019,68
4624,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2019,55
4633,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2019,75
4634,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2019,57
4637,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2019,79
4638,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2019,73
4641,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2019,86
4642,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2019,86
4657,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2019,80
4658,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2019,78
4659,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2019,42
4660,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2019,30
4661,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2019,83
4662,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2019,81
4671,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2019,69
4672,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2019,66
4681,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2019,79
4682,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2019,69
4683,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2019,59
4684,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2019,51
4685,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2019,89
4686,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2019,87
4687,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2019,68
4688,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2019,56
4689,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2019,25
4690,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2019,22
4693,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2019,54
4694,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2019,44
4697,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2019,82
4698,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2019,70
4701,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2019,46
4702,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2019,39
4703,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2019,63
4704,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2019,48
4713,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2019,72
4714,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2019,72
4717,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2019,92
4718,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2019,74
4719,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2019,65
4720,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2019,50
4721,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2019,58
4722,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2019,30
4727,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2019,52
4728,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2019,52
4731,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2019,35
4732,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2019,29
4735,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2019,69
4736,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2019,67
4737,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2019,76
4738,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2019,63
4741,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2019,64
4742,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2019,61
4743,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2019,86
4744,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2019,84
4745,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2019,80
4746,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2019,75
4751,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2019,69
4752,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2019,54
4753,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2019,95
4754,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2019,88
4757,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2019,14
4758,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2019,11
4761,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2019,69
4762,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2019,54
4763,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2019,77
4764,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2019,74
4767,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2019,91
4768,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2019,87
4769,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2019,98
4770,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2019,79
4771,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2019,92
4772,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2019,56
4777,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2019,76
4778,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2019,76
4781,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2019,77
4782,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2019,67
4783,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2019,24
4784,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2019,21
4785,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2019,86
4786,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2019,84
4787,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2019,52
4788,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2019,47
4795,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2019,83
4796,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2019,66
4797,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2019,80
4798,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2019,78
4799,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2019,44
4800,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2019,41
4805,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2019,28
4806,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2019,23
4807,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2019,85
4808,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2019,74
4809,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2019,56
4810,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2019,57
4811,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2019,65
4812,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2019,65
4813,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2019,79
4814,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2019,37
4817,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2019,70
4818,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2019,63
4823,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2019,86
4824,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2019,80
4825,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2019,91
4826,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2019,84
4827,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Afghanistan,AFG,2020,11
4828,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Afghanistan,AFG,2020,11
4835,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Argentina,ARG,2020,70
4836,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Argentina,ARG,2020,69
4837,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Australia,AUS,2020,83
4838,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Australia,AUS,2020,82
4851,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Benin,BEN,2020,91
4852,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Benin,BEN,2020,62
4855,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Bolivia,BOL,2020,57
4856,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Bolivia,BOL,2020,43
4857,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Botswana,BWA,2020,94
4858,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Botswana,BWA,2020,84
4861,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Burkina Faso,BFA,2020,93
4862,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Burkina Faso,BFA,2020,63
4865,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cabo Verde,CPV,2020,98
4866,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cabo Verde,CPV,2020,79
4875,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Chile,CHL,2020,69
4876,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Chile,CHL,2020,62
4877,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Colombia,COL,2020,81
4878,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Colombia,COL,2020,67
4887,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cote d'Ivoire,CIV,2020,80
4888,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cote d'Ivoire,CIV,2020,61
4891,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Cuba,CUB,2020,79
4892,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Cuba,CUB,2020,70
4895,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Denmark,DNK,2020,87
4896,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Denmark,DNK,2020,86
4911,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ethiopia,ETH,2020,83
4912,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ethiopia,ETH,2020,81
4913,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Fiji,FJI,2020,41
4914,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Fiji,FJI,2020,35
4915,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,France,FRA,2020,86
4916,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,France,FRA,2020,83
4925,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Greece,GRC,2020,71
4926,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Greece,GRC,2020,66
4935,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Haiti,HTI,2020,87
4936,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Haiti,HTI,2020,76
4937,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Honduras,HND,2020,59
4938,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Honduras,HND,2020,52
4939,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Iceland,ISL,2020,92
4940,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Iceland,ISL,2020,86
4941,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,India,IND,2020,68
4942,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,India,IND,2020,56
4943,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Indonesia,IDN,2020,28
4944,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Indonesia,IDN,2020,24
4947,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Jamaica,JAM,2020,49
4948,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Jamaica,JAM,2020,40
4951,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Kenya,KEN,2020,82
4952,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Kenya,KEN,2020,72
4955,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Latvia,LVA,2020,44
4956,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Latvia,LVA,2020,38
4957,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Lebanon,LBN,2020,66
4958,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Lebanon,LBN,2020,54
4967,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Luxembourg,LUX,2020,72
4968,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Luxembourg,LUX,2020,71
4971,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malawi,MWI,2020,96
4972,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malawi,MWI,2020,77
4973,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Malaysia,MYS,2020,65
4974,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Malaysia,MYS,2020,52
4975,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mali,MLI,2020,69
4976,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mali,MLI,2020,37
4981,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mexico,MEX,2020,58
4982,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mexico,MEX,2020,55
4985,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Mongolia,MNG,2020,38
4986,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Mongolia,MNG,2020,33
4989,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Morocco,MAR,2020,73
4990,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Morocco,MAR,2020,73
4991,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Myanmar,MMR,2020,80
4992,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Myanmar,MMR,2020,69
4995,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nepal,NPL,2020,67
4996,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nepal,NPL,2020,64
4997,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Netherlands,NLD,2020,88
4998,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Netherlands,NLD,2020,86
4999,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,New Zealand,NZL,2020,82
5000,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,New Zealand,NZL,2020,77
5005,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Nigeria,NGA,2020,86
5006,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Nigeria,NGA,2020,75
5007,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Norway,NOR,2020,97
5008,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Norway,NOR,2020,89
5011,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Pakistan,PAK,2020,15
5012,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Pakistan,PAK,2020,11
5015,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Paraguay,PRY,2020,71
5016,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Paraguay,PRY,2020,52
5017,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Peru,PER,2020,79
5018,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Peru,PER,2020,71
5021,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Rwanda,RWA,2020,93
5022,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Rwanda,RWA,2020,90
5023,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sao Tome and Principe,STP,2020,98
5024,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sao Tome and Principe,STP,2020,81
5025,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Senegal,SEN,2020,95
5026,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Senegal,SEN,2020,61
5031,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Singapore,SGP,2020,81
5032,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Singapore,SGP,2020,79
5035,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Africa,ZAF,2020,78
5036,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Africa,ZAF,2020,68
5037,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,South Sudan,SSD,2020,28
5038,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,South Sudan,SSD,2020,25
5039,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Spain,ESP,2020,87
5040,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Spain,ESP,2020,86
5041,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Sri Lanka,LKA,2020,62
5042,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Sri Lanka,LKA,2020,53
5049,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tanzania,TZA,2020,91
5050,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tanzania,TZA,2020,74
5051,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Thailand,THA,2020,84
5052,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Thailand,THA,2020,83
5053,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Timor-Leste,TLS,2020,50
5054,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Timor-Leste,TLS,2020,45
5059,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Tunisia,TUN,2020,31
5060,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Tunisia,TUN,2020,25
5061,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uganda,UGA,2020,86
5062,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uganda,UGA,2020,77
5063,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Ukraine,UKR,2020,61
5064,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Ukraine,UKR,2020,60
5065,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uruguay,URY,2020,66
5066,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uruguay,URY,2020,59
5067,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Uzbekistan,UZB,2020,84
5068,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Uzbekistan,UZB,2020,42
5071,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Vietnam,VNM,2020,73
5072,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Vietnam,VNM,2020,67
5077,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zambia,ZMB,2020,92
5078,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zambia,ZMB,2020,88
5079,Access to anti-retroviral drugs,female,%,SH.HIV.ARTC.FE.ZS,Zimbabwe,ZWE,2020,93
5080,Access to anti-retroviral drugs,male,%,SH.HIV.ARTC.MA.ZS,Zimbabwe,ZWE,2020,90
